CRIS Current Research Information System

MONALDI, CECILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.761
NA - Nord America 980
EU - Europa 724
AF - Africa 100
SA - Sud America 73
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 951
VN - Vietnam 761
SG - Singapore 401
CN - Cina 276
IT - Italia 273
HK - Hong Kong 113
DE - Germania 84
NL - Olanda 68
GB - Regno Unito 67
SE - Svezia 58
BR - Brasile 52
FR - Francia 40
IN - India 40
IE - Irlanda 38
KR - Corea 34
TG - Togo 34
BD - Bangladesh 25
CI - Costa d'Avorio 25
RU - Federazione Russa 22
CA - Canada 20
FI - Finlandia 18
ZA - Sudafrica 16
JP - Giappone 14
JO - Giordania 13
NG - Nigeria 13
IQ - Iraq 12
TW - Taiwan 12
IR - Iran 11
PL - Polonia 11
TH - Thailandia 10
AT - Austria 8
EC - Ecuador 6
ES - Italia 6
PH - Filippine 6
UA - Ucraina 6
AR - Argentina 5
CH - Svizzera 5
ID - Indonesia 5
MX - Messico 5
SA - Arabia Saudita 5
SC - Seychelles 5
BG - Bulgaria 4
AU - Australia 3
EE - Estonia 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
PS - Palestinian Territory 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 3.642
Salva come PNG Salva come JPEG
Città #
Singapore 312
Ho Chi Minh City 248
Hanoi 187
Chandler 114
Ashburn 110
Hong Kong 103
San Jose 93
Bologna 68
Hefei 61
Southend 50
Dublin 38
Lomé 34
Beijing 33
Fairfield 33
Santa Clara 30
Seoul 29
Abidjan 25
Princeton 24
Boardman 22
Haiphong 22
Milan 22
Da Nang 20
Ha Long 20
Redmond 20
Frankfurt am Main 19
Wilmington 19
Houston 17
Biên Hòa 16
Lauterbourg 15
Los Angeles 15
New York 14
Rome 14
Woodbridge 14
Redondo Beach 13
Seattle 13
Thái Nguyên 13
Abeokuta 12
Berlin 12
Council Bluffs 12
Tokyo 12
Johannesburg 11
Cambridge 10
Amman 9
Tehran 9
Turin 9
Hải Dương 8
Montreal 8
Nuremberg 8
Shanghai 8
São Paulo 8
Vũng Tàu 8
Bengaluru 7
Buffalo 7
Bắc Ninh 7
Dallas 7
Guangzhou 7
Lappeenranta 7
Munich 7
Quận Bình Thạnh 7
Warsaw 7
Zhengzhou 7
Điện Bàn 7
Chicago 6
Florence 6
Helsinki 6
London 6
Ninh Bình 6
San Diego 6
Tianjin 6
Vinh 6
Ann Arbor 5
Atlanta 5
Bangkok 5
Bern 5
Boydton 5
Brescia 5
Brooklyn 5
Bến Tre 5
Falkenstein 5
Huế 5
Nha Trang 5
Phoenix 5
Quận Hai 5
Quận Phú Nhuận 5
Quận Sáu 5
Shenyang 5
Thái Bình 5
Turku 5
Baghdad 4
Boston 4
Can Tho 4
Catania 4
Changsha 4
Dehradun 4
Des Moines 4
Lang Son 4
Medford 4
Nanjing 4
Phủ Lý 4
Quảng Ngãi 4
Totale 2.307
Salva come PNG Salva come JPEG
Nome #
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 662
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 283
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 228
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities 176
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 173
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells 172
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 167
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy 164
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 163
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 162
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 157
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia 156
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 153
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 145
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort? 135
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis 122
Systemic mastocytosis: Molecular landscape and implications for treatment 122
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia 111
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors 109
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability 75
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia 68
Totale 3.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022200 4 2 6 4 22 13 2 21 14 15 57 40
2022/2023426 44 73 17 34 44 24 24 17 78 15 44 12
2023/2024144 2 27 14 22 13 13 7 19 3 10 11 3
2024/2025688 24 122 63 51 39 24 79 33 20 70 66 97
2025/20262.042 201 569 109 139 152 60 139 46 370 107 102 48
Totale 3.703